ConductScience.org, home

Paper41155893

Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.

Li J and 8 others. Pharmaceutics, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer. Papers, record 41155893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41155893

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.
PubMed
Journal
Pharmaceutics
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-17
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JJialinghttps://orcid.org/0009-0009-9386-453X
2Han NNing
3Ruan MMingyuehttps://orcid.org/0000-0001-6801-5215
4Wei HHongmei
5Dong YYunan
6Zhang HHaitong
7Guo ZZishuo
8Du SShouyinghttps://orcid.org/0000-0003-3827-3277
9Li PPengyuehttps://orcid.org/0000-0001-6548-0779

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82274111National Natural Science Foundation of ChinaPubMed
ZYYZDXK-2023272Level Construction Disciplines of State Administration of Traditional Chinese Medicine Traditional Chinese Medicine PharmacyPubMed

Source PubMed

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134936300Potential of Curcumin and Quercetin in Modulation of Premature Mitochondrial Senescence and Related Changes during Lung Carcinogenesis.J Environ Pathol Toxicol Oncol2021https://conductscience.org/library/papers/34936300PubMed
238417295Degradable bifunctional phototherapy composites based on upconversion nanoparticle-metal phenolic network for multimodal tumor therapy in the near-infrared biowindow.J Colloid Interface Sci2024https://conductscience.org/library/papers/38417295PubMed
333856772Facile, Smart, and Degradable Metal-Organic Framework Nanopesticides Gated with FeIII-Tannic Acid Networks in Response to Seven Biological and Environmental Stimuli.ACS Appl Mater Interfaces2021https://conductscience.org/library/papers/33856772PubMed
435880107Curcumin Alleviates D-Galactose-Induced Cardiomyocyte Senescence by Promoting Autophagy via the SIRT1/AMPK/mTOR Pathway.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35880107PubMed
536272661Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy.J Control Release2022https://conductscience.org/library/papers/36272661PubMed
636333962Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.Wiley Interdiscip Rev Nanomed Nanobiotechnol2023https://conductscience.org/library/papers/36333962PubMed
727683187Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.Eur J Drug Metab Pharmacokinet2017https://conductscience.org/library/papers/27683187PubMed
835041678Curcumin suppresses tumorigenesis by ferroptosis in breast cancer.PLoS One2022https://conductscience.org/library/papers/35041678PubMed
934623753Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.Small2021https://conductscience.org/library/papers/34623753PubMed
1033656766Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy.Thorac Cancer2021https://conductscience.org/library/papers/33656766PubMed
1135695187Intrinsically Bioactive Manganese-Eumelanin Nanocomposites Mediated Antioxidation and Anti-Neuroinflammation for Targeted Theranostics of Traumatic Brain Injury.Adv Healthc Mater2022https://conductscience.org/library/papers/35695187PubMed
1238686676Self-Assembled Fe-Phenolic Acid Network Synergizes with Ferroptosis to Enhance Tumor Nanotherapy.Small2024https://conductscience.org/library/papers/38686676PubMed
1338014635Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.Cell Biochem Funct2023https://conductscience.org/library/papers/38014635PubMed
1440871054Palladium Complex-Loaded Magnetite Nanoparticles as Drug Delivery Systems for Targeted Liver Cancer Therapy.Pharmaceutics2025https://conductscience.org/library/papers/40871054PubMed
1524192454Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.Pharm Dev Technol2014https://conductscience.org/library/papers/24192454PubMed
1639821470Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways.Funct Integr Genomics2025https://conductscience.org/library/papers/39821470PubMed
1738527739[Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China(2024 edition)].Zhonghua Zhong Liu Za Zhi2024https://conductscience.org/library/papers/38527739PubMed
1833294119Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells.Oxid Med Cell Longev2020https://conductscience.org/library/papers/33294119PubMed
1931896509AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis.Redox Biol2020https://conductscience.org/library/papers/31896509PubMed
2015325031Endothelial cell effects of cytotoxics: balance between desired and unwanted effects.Cancer Treat Rev2004https://conductscience.org/library/papers/15325031PubMed

See all 31 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42797301Study on Echinacoside-Copper Metal-Phenolic Networks Hydrogel System Loaded with Diallyl Trisulfide for Local Treatment of Cervical Cancer.Pharmaceutics2026https://conductscience.org/library/papers/42797301PubMed
42781638TRAIL of Hope: Bioactive Dietary Component-Driven Carrier-Free Nanoplatforms for Synergistically Enhanced Tumor Multimodal Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42781638PubMed
42514903Curcumin as a Synergy Amplifier in Cancer Therapy.Pharmaceutics2026https://conductscience.org/library/papers/42514903PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41155893

GET https://conductscience.org/api/papers/v1/41155893/references?page=2